Survey Participation Request

Would you be interested in taking a brief survey on your experience in visiting our website?

Please note: No personal information will be collected.

Thank you for your participation.The Information provided will be used in the aggregate and will not be shared with any other companies that are not under the direction of Novartis Oncology.

What type of patients with KIT+ gastrointestinal stromal tumors (GIST) do you treat? (Check all that apply)
Patients with operable primary KIT+ GIST Patients with unresectable or metastatic KIT+ GIST
Are you currently treating your KIT+ gastrointestinal stromal tumor (GIST) patients with Glivec?
Yes No
Why did you visit www.glivec.com today? (Check all that apply)
To learn about treatment of patients with KIT+ gastrointestinal stromal tumors (GIST) To learn how to dose and administer Glivec for my KIT+ gastrointestinal stromal tumors (GIST) patients To learn about safety information for Glivec To get information for my KIT+ gastrointestinal stromal tumors (GIST) patients To use KIT+ gastrointestinal stromal tumors (GIST) risk of recurrence calculator To learn the mechanism of action of Glivec To learn if there is any new data about the treatment of KIT+ gastrointestinal stromal tumors (GIST) with Glivec To learn about treatment of patients with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia Other